When you run your numbers and come up with a discounted NPV on future cash flows or however you choose to do it, can you try to include some additional indications based on the assumption that we get a domino effect. I’m sure you have considered this and it will be interesting to try to predict which indications they go for next and how quickly we can expand the approvals for Vaxinia and Azer-Cel. Azer-Cel could in fact be the first approved Allogeneic CAR T and could be also be the first approved for solid tumours.
This could get crazy really fast.
When you run your numbers and come up with a discounted NPV on...
-
- There are more pages in this discussion • 7,193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.2¢ | 4.9¢ | $531.4K | 10.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3429444 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 149299 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |